Clinical Trials

100 enrolled

Cytokine Release Syndrome, Lymphoma, Non-Hodgkin, Recurrence, Lymphoma, Large B-Cell, Diffuse

NCT04984837 2026-04-20

Study of Lacutamab in Peripheral T-cell Lymphoma

56 enrolled

Recurrence, Lymphoma, T-Cell, Lymphoma, T-Cell, Peripheral

NCT07001540 2025-06-19

Evaluation of the Efficacy and Safety of Polatuzumab Vedotin Combined With Rituximab, Gemcitabine, and Oxaliplatin (Pola-R-GemOx) as Salvage Therapy for Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL) Patients Ineligible for Autologous Transplantation

130 enrolled

Recurrence, Lymphoma, Large B-Cell, Diffuse

NCT05476796 2024-10-24

LOGICAN

118 enrolled

Adenocarcinoma Of Esophagus, Adenocarcinoma, Neoplasm Metastasis, Recurrence

NCT03422523 2022-08-22

ARGO

Phase 2 Terminated

53 enrolled

Recurrence, Lymphoma, Large B-Cell, Diffuse

NCT01283204 2019-01-29

Trial of 4-regimen (SP, FL/Tax, FL/Doc, FOLFOX) in Patients With Recurrent or Metastatic Gastric Cancer

180 enrolled

Recurrence, Stomach Neoplasms

NCT03585673 2018-07-17

DOSE

Phase 2 Unknown

38 enrolled

Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms, Neoplasm Metastasis, Recurrence

NCT00336583 2018-06-26

Etoposide, Methylprednisolone, High-dose Cytarabine and Oxaliplatin as 2nd Line Therapy for Non-Hodgkin's Lymphoma (NHL)

27 enrolled 8 charts

Lymphoma, Non-Hodgkin, Recurrence

NCT01364493 2017-05-09

A Study to Evaluate the Efficacy and Safety of Trastuzumab in Combination With Capecitabine and Oxaliplatin as First-line Chemotherapy for Inoperable, Locally Advanced or Recurrent and/or Metastatic Gastric Cancer

51 enrolled

Neoplasm Metastasis, Recurrence, Stomach Neoplasms

NCT00612677 2017-03-23

Pemetrexed &Oxaliplatin in Patients w Recurrent NSCLCa After Failure to Platinum Based Adjuvant Chem

Phase 2 Terminated

1 enrolled 3 charts

Thoracic

Lung Neoplasms, Recurrence

NCT01068392 2014-11-04

Oxaliplatin and Prednisolone (Ox-P) for Patients With Relapsed or Refractory Marginal Zone B-cell Lymphoma(MZL)

42 enrolled

Recurrence, Lymphoma, B-Cell, Lymphoma, B-Cell, Marginal Zone

NCT01481701 2014-10-15

A Trial Evaluating Efficacy and Safety of Oxaliplatin With 5-Fluorouracil in Patients With Recurrent Ovarian Carcinoma

90 enrolled

Gynecologic

Ovarian Neoplasms, Recurrence

NCT00557206 2013-11-05

Oxaliplatin and Docetaxel for Recurrent or Metastatic Head and Neck Cancer

Phase 2 Terminated

35 enrolled

Head & Neck

Carcinoma, Squamous Cell, Head and Neck Neoplasms, Neoplasm Metastasis, Neoplasms, Recurrence

NCT01262482 2012-11-09

Study of Oxaliplatin and Sorafenib Combination to Treat Gastric Cancer Relapsed After a Cisplatin Based Treatment

41 enrolled

Adenocarcinoma, Recurrence

NCT00356122 2011-10-17

Docetaxel & Oxaliplatin in Combination With Bevacizumab as First-Line Treatment in Subjects With Non-Small Cell Lung Cancer (NSCLC)

53 enrolled 14 charts

Thoracic

Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis, Neoplasms, Recurrence

NCT00961077 2009-08-18

Attenuated SOX as First-line Treatment in Elderly Patients With Relapsed or Metastatic Gastric Cancer

Phase 2 Unknown

36 enrolled

Recurrence, Stomach Neoplasms

NCT00510107 2007-08-01

Weekly Docetaxel Plus Cisplatin or Oxaliplatin for AGC

Phase 2 Unknown

90 enrolled